Tags

Type your tag names separated by a space and hit enter

Current issues and trends in the diagnosis and treatment of adults with ADHD.
Expert Rev Neurother. 2007 Oct; 7(10):1375-90.ER

Abstract

Attention-deficit/hyperactivity disorder (ADHD) has been commonly thought of as a childhood disorder that diminished over time. It is one of the most common developmental disorders and it is estimated that ADHD affects 5-10% of children. Two-thirds of children with ADHD will continue to have symptoms of ADHD that persist throughout adolescence. Longitudinal studies have demonstrated that symptoms of ADHD can also remain in adulthood, affecting 4.4% of the adult population. However, diagnosing adults with ADHD can prove difficult because they often find that their symptoms are egosyntonic. In addition, the development of comorbid conditions, such as anxiety, depression, personality disorders or substance abuse, can often overshadow underlying ADHD symptoms. Nonetheless, treatments such as stimulant and nonstimulant medication (e.g., atomoxetine), and cognitive-behavior therapy have been effective in treating adults with ADHD. This article reviews the prevalence of adults with ADHD, followed by a discussion of the neurobiological and genetic underpinnings of the disorder. Issues regarding the diagnosis and treatment of ADHD are also addressed.

Authors+Show Affiliations

McGill University, Department of Educational & Counselling Psychology, 3700 McTavish St., Montreal, Quebec, H3A 1Y2. lucy.cumyn@mail.mcgill.caNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

17939773

Citation

Cumyn, Lucy, et al. "Current Issues and Trends in the Diagnosis and Treatment of Adults With ADHD." Expert Review of Neurotherapeutics, vol. 7, no. 10, 2007, pp. 1375-90.
Cumyn L, Kolar D, Keller A, et al. Current issues and trends in the diagnosis and treatment of adults with ADHD. Expert Rev Neurother. 2007;7(10):1375-90.
Cumyn, L., Kolar, D., Keller, A., & Hechtman, L. (2007). Current issues and trends in the diagnosis and treatment of adults with ADHD. Expert Review of Neurotherapeutics, 7(10), 1375-90.
Cumyn L, et al. Current Issues and Trends in the Diagnosis and Treatment of Adults With ADHD. Expert Rev Neurother. 2007;7(10):1375-90. PubMed PMID: 17939773.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Current issues and trends in the diagnosis and treatment of adults with ADHD. AU - Cumyn,Lucy, AU - Kolar,Dusan, AU - Keller,Amanda, AU - Hechtman,Lily, PY - 2007/10/18/pubmed PY - 2007/12/6/medline PY - 2007/10/18/entrez SP - 1375 EP - 90 JF - Expert review of neurotherapeutics JO - Expert Rev Neurother VL - 7 IS - 10 N2 - Attention-deficit/hyperactivity disorder (ADHD) has been commonly thought of as a childhood disorder that diminished over time. It is one of the most common developmental disorders and it is estimated that ADHD affects 5-10% of children. Two-thirds of children with ADHD will continue to have symptoms of ADHD that persist throughout adolescence. Longitudinal studies have demonstrated that symptoms of ADHD can also remain in adulthood, affecting 4.4% of the adult population. However, diagnosing adults with ADHD can prove difficult because they often find that their symptoms are egosyntonic. In addition, the development of comorbid conditions, such as anxiety, depression, personality disorders or substance abuse, can often overshadow underlying ADHD symptoms. Nonetheless, treatments such as stimulant and nonstimulant medication (e.g., atomoxetine), and cognitive-behavior therapy have been effective in treating adults with ADHD. This article reviews the prevalence of adults with ADHD, followed by a discussion of the neurobiological and genetic underpinnings of the disorder. Issues regarding the diagnosis and treatment of ADHD are also addressed. SN - 1744-8360 UR - https://www.unboundmedicine.com/medline/citation/17939773/Current_issues_and_trends_in_the_diagnosis_and_treatment_of_adults_with_ADHD_ L2 - https://www.tandfonline.com/doi/full/10.1586/14737175.7.10.1375 DB - PRIME DP - Unbound Medicine ER -